THU0053 Anti-fractalkine monoclonal antibody ameliorates joint destruction in collagen-induced arthritis model by inhibition of osteoclast precursor cell survival and migration
Kuboi, Y., Hoshino-Negishi, K., Ohkuro, M., Ikeda, W., Nakatani, T., Ishii, N., Yasuda, N., Imai, T.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
THU0031 Therapeutic treatment of anti-fractalkine monoclonal antibody inhibits joint destruction in collagen-induced arthritis model
Hoshino-Negishi, K, Ohkuro, M, Nakatani, T, Ikeda, W, Kuboi, Y, Ishii, N, Yamauchi, T, Yasuda, N, Imai, T
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases
Tanaka, Yoshiya, Hoshino-Negishi, Kana, Kuboi, Yoshikazu, Tago, Fumitoshi, Yasuda, Nobuyuki, Imai, Toshio
Published in ImmunoTargets and therapy (01.01.2020)
Published in ImmunoTargets and therapy (01.01.2020)
Get full text
Journal Article